Skip to content
Back to Blog
Government Programs
2026-09-297 min read12

Government R&D Shifts from Grants to Equity — What the New KRW 20 Billion Private-Cooperation Investment-Type R&D Program Changes

The new KRW 20 billion Private-Cooperation Investment-Type R&D program in Korea's 2027 budget proposal puts government R&D money into companies as equity rather than grants. This post covers how it differs from grant-type R&D and which companies it suits.

KITIM Consulting Team

R&D Money That Arrives as Equity, Not Grants

Debates about Korea's government R&D budget usually focus on the headline total. This change is about something else: how the money is delivered. Until now, R&D support for SMEs has come only as grants or subsidies. The Ministry of SMEs and Startups now plans to add an equity investment option. The plan to introduce investment-type R&D was announced in April 2026. It became concrete when a new line item, the `Private-Cooperation Investment-Type R&D` program, appeared in the 2027 budget proposal.

Here is what the budget proposal includes:

  • Fund contribution: KRW 20 billion in 2027
  • Matching: government and private capital matched 1:1
  • Eligibility: SMEs and ventures in the seven SEED sectors that have already raised at least KRW 1 billion from private investors
  • Scale: about KRW 1 billion per company, for roughly 20 companies
  • How the Money Flows In and Out

    A dedicated R&D fund will be set up at Korea Venture Investment Corp. (KVIC), and the fund will take equity stakes in the selected companies. The companies must spend all of the invested capital on R&D. If a company succeeds through an IPO or M&A, the fund sells its stake, recovers the principal plus any gains, and puts that money back into R&D. If the technology or its commercialization fails and the stake loses value, the government absorbs part of the loss.

    Screening happens in three stages:

  • A VC assesses the company's valuation and growth potential and recommends it.
  • TIPA (Korea Technology and Information Promotion Agency for SMEs) evaluates the R&D project.
  • KVIC's investment committee reviews the valuation and growth potential again.
  • | Item | Grant-type R&D | Investment-type R&D |

    |---|---|---|

    | Nature | Project funding | Equity stake in the company |

    | Funding type | Grant (non-repayable) | Paid-in capital |

    | If successful | Technology fees owed | Fund exits by selling its stake |

    | If unsuccessful | Limited liability if the project was performed in good faith | Government shares the equity loss |

    | Dilution | None | Yes |

    The TIPS-style investment-linked programs work differently. There, private investors put money in first and the government follows with an R&D grant. In the new program, the government's own money goes in as equity.

    Is It Right for Your Company? Four Tests

    1. Prerequisites. Check whether you have at least KRW 1 billion in private investment, whether you fall within the seven SEED sectors, and whether one of your existing investors could realistically recommend you.

    2. Dilution. Work out what share of the company KRW 1 billion buys at your current valuation. Check how it affects the structure of your next round, and review your existing investment agreements for shareholder consent rights or limits on issuing new shares. Note that, according to the budget explanatory materials, the combined private and government stake is to be capped below 15% to protect founder control.

    3. Balance sheet effects. Depending on the accounting standard and when the funds are used, a grant is recorded either as a liability (deferred income) or as a cost offset or income. Equity goes straight into capital, which raises equity and lowers your debt ratio. That difference can matter in bank credit reviews and in the financial evaluations used for procurement bids.

    4. When it's a poor fit. The existing grant track may be the better choice for:

  • family-owned businesses that don't want to give up ownership
  • companies with no IPO or M&A plans, and therefore no clear exit path
  • companies that already have enough funding from grant-type projects
  • Still a Budget Proposal: Plan Accordingly

    This program is still a line item in the 2027 budget proposal. The National Assembly's review and the detailed implementation plan may change the timing of the call and the eligibility rules. Running an equity-based program also requires updates to related rules, such as the legal categories of national R&D support and the rules for recovering funds.

    You can prepare now in three ways:

  • Build out your private fundraising track.
  • Frame your technology roadmap and commercialization plan so they hold up in an investment committee review.
  • Plan how the new funding would relate to any grant-funded projects you already run, so the two don't overlap and ideally reinforce each other.
  • The KITIM View: Plan Both Funding Paths Together

    Investment-type R&D doesn't replace grants. It adds another option. Whether you belong on a grant track, such as the Technology Innovation Development or Startup Growth programs, or on the investment track depends on your funding stage, your exit plan, and your cap table. The investment track asks for technical merit and an investment case (valuation and exit scenarios) in a single document, so your business plan needs to cover both from the start.

    KITIM designs funding strategies that consider grant-type and investment-type R&D side by side. Start with our free company diagnosis and AI program matching to see which R&D tracks you can apply for today. If you want to prepare for investment-type R&D, contact the KITIM consulting team.

    Investment-Type R&DPrivate Cooperation Investment R&DEquity InvestmentKorea Venture InvestmentSEED SectorsTechnology Fee

    Related Posts

    Bio

    Biologics Approval Fees Rise From KRW 8.03M to 20.71M, Data-Submission Drugs About 6x — MFDS Fee Regulation Amendment Pre-Announced Nov 6, 2026 (Comments Due Nov 26 / Dec 16): Filing Timing, Budget Review and Fee-Reduction Checks for Pharma & Bio SMEs

    Under the fee amendment MFDS proposed on November 6, approval fees for new biologics would rise from KRW 8.03 million to KRW 20.71 million, and fees for data-submission drugs would go up about sixfold. This guide shows pharma and bio SMEs how to review their filing timing, budgets, fee-reduction eligibility and public comments.

    2026-11-09
    Management Consulting

    Factories With 20–49 Workers Will Need a Safety or Health Manager — Korea's First Tripartite Agreement on November 5 (About 30,000 Sites in 5 Industries Including Manufacturing, Decree Amendment in 2027, Target Start 2028), the Owner-Led Alternative and Government Payroll Support: A Preparation Guide for Small Manufacturers

    Under Korea's November 5 tripartite agreement, about 30,000 sites with 20–49 workers in manufacturing and four other industries are expected to need a qualified safety or health manager from 2028. This guide covers what is settled and what is still open, the owner-led alternative, a cost comparison, and a preparation checklist.

    2026-11-09
    Government Programs

    SMEs Can Now Enter the KRW 1,500 Trillion 'Mega Project' Supply Chain from the Design Stage — MSS Joins as a Lead Ministry, Large/Mid-Tier–SME Councils and Regional Councils Launch (Nov 6 Plan to Expand Planning-Stage Participation), and How SMEs Targeting Semiconductor, AI Data Center and Physical AI Supply Chains Should Prepare Validation, Certification and Mass-Production Qualification

    MSS has joined Korea's KRW 1,500 trillion mega projects as a lead ministry and plans to bring SMEs in from the planning stage. This guide covers how the central and regional councils will work and how to line up support programs against the validation, certification and mass-production barriers.

    2026-11-09
    Updated daily

    Let AI find government support programs in this field

    Complete a 3-minute company assessment and we will recommend programs that fit your company, each with a match score. It is free.

    Get AI-Matched Programs for Free

    Need Consulting?

    Our technology innovation consultants will propose the optimal solution for your company.